Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep;98(9):E237-E240.
doi: 10.1002/ajh.27009. Epub 2023 Jun 29.

Continuous venetoclax in treatment-naive TP53 disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus study

Andrea Visentin  1   2 , Francesca Romana Mauro  3 , Lydia Scarfò  4 , Massimo Gentile  5   6 , Lucia Farina  7 , Gianluigi Reda  8 , Isacco Ferrarini  9 , Giulia Proietti  3 , Enrico Derenzini  10 , Francesca Cibien  11 , Candida Vitale  12 , Alessandro Sanna  13 , Daniela Pietrasanta  14 , Monia Marchetti  14 , Roberta Murru  15 , Gian Matteo Rigolin  16 , Paolo Sportoletti  17 , Valentina Trimarco  1 , Chiara Adele Cavarretta  1 , Francesco Angotzi  1 , Alessandro Cellini  1 , Valeria Ruocco  1 , Ivan Zatta  1 , Luca Laurenti  18 , Stefano Molica  19 , Marta Coscia  12 , Paolo Ghia  4 , Robin Foà  3 , Antonio Cuneo  16 , Livio Trentin  1   2
Affiliations
Free article

Continuous venetoclax in treatment-naive TP53 disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus study

Andrea Visentin et al. Am J Hematol. 2023 Sep.
Free article
No abstract available

PubMed Disclaimer

References

REFERENCES

    1. Burger JA. Treatment of chronic lymphocytic leukemia. N Engl J Med. 2020;383(5):460-473.
    1. Baliakas P, Jeromin S, Iskas M, et al. Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact. Blood. 2019;133(11):1205-1216.
    1. Visentin A, Bonaldi L, Rigolin GM, et al. The complex karyotype landscape in chronic lymphocytic leukemia allows to refine the risk of Richter syndrome transformation. Haematologica. 2021;107:868-876.
    1. Morabito F, Del Poeta G, Mauro FR, et al. TP53 disruption as a risk factor in the era of targeted therapies: a multicenter retrospective study of 525 chronic lymphocytic leukemia cases. Am J Hematol. 2021;96:E306-E310.
    1. Rigolin GM, Del Giudice I, Bardi MA, et al. Complex karyotype in unfit patients with Cll treated with ibrutinib and rituximab. The Gimema Llc1114 phase 2 study. Blood. 2021;138:2727-2730.

Publication types

MeSH terms

LinkOut - more resources